Guidelines for Assigning Summary Stage 2000

Similar documents
Staging and Treatment Update for Gynecologic Malignancies

SEER Summary Stage Still Here!

5/8/2014. AJCC Stage Introduction and General Rules. Acknowledgements* Introduction. Melissa Pearson, CTR North Carolina Central Cancer Registry

Interactive Staging Bee

Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

Exercise 15: CSv2 Data Item Coding Instructions ANSWERS

New Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%

What is endometrial cancer?

Cervical Cancer: 2018 FIGO Staging

Case Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue

NAACCR Webinar Series 1 Q&A. Fabulous Prizes. Collecting Cancer Data: Ovary 11/3/2011. Collecting Cancer Data: Ovary

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment

GENERAL DATA. Sex : female Age : 40 years old Marriage status : married

Quiz. b. 4 High grade c. 9 Unknown

Q&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1

Endometrial Cancer. Incidence. Types 3/25/2019

Ovarian Tumors. Andrea Hayes-Jordan MD FACS, FAAP Section Chief, Pediatric Surgery/Surgical Onc. UT MD Anderson Cancer Center

2009 USCAP Gyn Pathology Evening Session Case #3. Richard J. Zaino, MD Hershey Medical Center Penn State University Hershey, PA

Summary Stage 2018 (SS2018)

Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE

2018 Implementation: SEER Summary Stage 2018

I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a product in my presentation.

Staging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion

Prostate Case Scenario 1

Birthday: 1952/07/31 Date of admission:1999/12/30 Age:48 y/o Past medication:esrd under regular HD for 5+ years; denied DM and HTN

Uterus Malignancies /5/15

Staging for Residents, Nurses, and Multidisciplinary Health Care Team

North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer

ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation *

8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

Completing the Puzzle AJCC TNM Staging Breast. Nicole Catlett, CTR 2017 Kentucky Cancer Registry Fall Conference, September 21 & 22, 2017

North of Scotland Cancer Network Clinical Management Guideline for Cancer of the Ovary

Cervical cancer presentation

Q: In order to use the code 8461/3 (serous surface papillary) for ovary, does it have to say the term "surface" on the path report?

A schematic of the rectal probe in contact with the prostate is show in this diagram.

Histology Coding ANSWERS

AJCC-NCRA Education Needs Assessment Results

Cervical Cancer 3/25/2019. Abnormal vaginal bleeding

11/21/13 CEA: 1.7 WNL

Major Rule Changes. Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging

Collecting Cancer Data: Lung

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

2018 Summary Stage PEGGY ADAMO, RHIT, CTR OCTOBER 11, 2018

Quiz 1: Terminology and Anatomy

Ovarian Cancer Includes Epithelial, Fallopian Tube, Primary Peritoneal Cancer, and Ovarian Germ Cell Tumors

Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru

PORTEC-4. Patient seqnr. Age at inclusion (years) Hospital:

Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix.

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

UICC 8 th Edition Errata 25 th of May 2018

Testicular Malignancies /8/15

Case Scenario 1: Breast

Case Scenario 1. 1/2/13 History: 64-year-old white female presented with right leg swelling and redness, abdominal pain.

Definition of Synoptic Reporting

Gynecologic Oncologist. Surgery Chemotherapy Radiation Therapy Hormonal Therapy Immunotherapy. Cervical cancer

Uterine Malignancies. Collecting Cancer Data: Uterine Malignancies 10/7/2010. NAACCR Webinar Series 1. Questions. Fabulous Prizes!!!

Case Scenario 1. 1/2/13 History: 64-year-old white female presented with right leg swelling and redness, abdominal pain.

Alison Douglass Gillian Lieberman, MD. November. Colon Cancer. Alison Douglass, Harvard Medical School Year III Gillian Lieberman, MD

Directly Coded Summary Stage Breast Cancer

OFCCR CLINICAL DIAGNOSIS AND TREATMENT FORM

Collecting Cancer Data: Prostate Q&A. Overview. NAACCR Webinar Series June 11, 2009

Type I. Type II. Excess estrogen Lynch Endometrioid adenocarcinoma PTEN. High grade More aggressive Serous, Clear Cell p53

NAACCR Webinar Series /7/17

The new FIGO classification in endometrial carcinoma

Directly Coded Summary Stage Melanoma

Current staging of endometrial carcinoma with MR imaging

INTRODUCTION TO CANCER STAGING

UICC TNM 8 th Edition Errata

ARROCase: Locally Advanced Endometrial Cancer

STAGE CATEGORY DEFINITIONS

Carcinoma of the Fallopian Tube

Winship Cancer Institute of Emory University Optimizing First Line Treatment of Advanced Ovarian Cancer

Boot Camp Case Scenarios

This form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.

Pre-operative Evaluation and Implications

NEW JERSEY STATE CANCER REGISTRY

Requirements for Abstracted Text

UICC TNM 8 th Edition Errata

This form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.

UTERINE SARCOMA EXAMPLE OF A UTERINE SARCOMA USING PROPOSED TEMPLATE

Seventh Edition Staging 2017 Colorectum. Overview. This webinar is sponsored by. the Centers for Disease Control and Prevention.

North of Scotland Cancer Network Clinical Management Guideline for Carcinoma of the Uterine Cervix

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

4/10/2018. SEER EOD and Summary Stage. Overview KCR 2018 SPRING TRAINING. What is SEER EOD? Ambiguous Terminology General Guidelines

Vaginal Cancer Early Detection, Diagnosis, and Staging

Collaborative Staging

Jacqui Morgan March 6, 2019

LUNG STAGING FORM LATERALITY: LEFT RIGHT BILATERAL

6. Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck

H&E, IHC anti- Cytokeratin

Seventh Edition Staging 2017 Breast

Colon and Rectum 5/1/14

George Cernile Artificial Intelligence in Medicine Toronto, ON. Carol L. Kosary National Cancer Institute Rockville, MD

Transcription:

Guidelines for Assigning Summary Stage 2000 Mary Lewis, CTR National Program of Cancer Registries 2014 NCRA Annual Meeting May 17, 2014 National Center for Chronic Disease Prevention and Health Promotion

Outline: 1. Review of General Guidelines 2. Detailed review of primary s of : a. Female Breast b. Lung c. Colo-rectal d. Prostate e. Uterus

In situ: General Guidelines What can be ruled out? Only apply to carcinomas and melanoma Must be microscopically examined Can not have evidence of invasion, nodal involvement or metastatic spread Distant: STOP once distant disease is identified Systemic Disease Review reports Localized: Rule out confined to organ or origin Be careful of terms: blood vessel or perineural invasion Vascular Invasion isn t determining factor

Regional: General Guidelines continued: If other stages have been ruled out then the stage is Regional. Lymph Node involvement stage is at least regional-nodes Assume ipsilateral unless stated Unknown: Unknown Primary Site Not enough information Source: SEER Summary Stage Manual 2000 http://www.seer.cancer.gov/tools/ssm/sssm2000-122012.pdf

Breast Sources of Information: Diagnostic Studies: Physical Examination: Mass, size, ulceration, swelling, fixation, palpable lymph nodes Imaging Mammogram Unilateral, bilateral, contralateral Surgical Pathology: Cell Type, tumor size, number of lesions Lymph node involvement Extension to adjacent tissue

Breast - Assigning Summary Stage 2000 In situ: Synonymous Terms Pathology Report Local: Pathology Physical Examination Regional Direct Extension: Physical Exam includes: Skin edema, Peau d orange, Inflammation Skin ulceration

Breast - Assigning Summary Stage 2000 Regional Lymph Nodes: Pathology Report Nodules in fat Nodes, NOS Axillary Lymphadenopathy Distant: Scans and Xrays: Distant Lymph Nodes Contiguous Extension Bone, Lung MRI Physical Exam/Consult Reports/Pathology Reports

Lung Sources of Information: Diagnostic Studies: Chest x-ray Imaging, Lung Esophagogram Imaging, Bone Imaging, Brain Imaging, Liver/spleen Bronchoscopy Mediastinoscopy Esophagoscopy Thoroscopy Laryngoscopy

Lung Assigning Summary Stage: Radiographic Exams: Chest X-ray CT Scans MRI Operative Report Review Findings Pathology: Cell Type Bone Marrow Biopsy Cytology, Bronchial Washings Closed Chest Needle Biopsy

In situ: Lung Assigning Summary Stage: Pathology, Cytology, Aspirate Localized: Bronchoscopy Chest Xray CT Scans, MRI Regional Direct Extension: Bronchoscopy Chest Xray CT Scans, MRI

Lung Assigning Summary Stage: Regional Lymph Node Chest Xray/CT Scans Hilar Nodes Peri-aortic Nodes Mediastinal Nodes Distant CT Scans, MRI Pleural Effusion Separate tumor nodules in different lobe Separate tumor nodules in contralateral lung Distant Lymph Nodes Distant Metastasis

Colo-Rectal Sources of Information: Diagnostic Studies: Physical Exam: Abdomen masses, enlarged organs, palpable nodes, jaundice Rectal bleeding, palpable tumor, fixation Imaging: Barium Enema, Small Bowel series, Chest x-ray, Imaging of Abdomen/Pelvis, Liver/Spleen, Brain and Bone. Endoscopies: Colonoscopy, Sigmoidoscopy, Cystoscopy

Colo-Rectal Sources of Information Operative Report Anatomic Site, Lymph Nodes Gross Tumor Involvement Pathology: Cell Type Tumor Size Location of tumor Extension Dukes Staging Biopsy results of additional tumor sites Number of Lymph Nodes

In situ: Colo-Rectal Assigning Summary Stage Pathologic Examination (Adeno)carcinoma in a polyp or adenoma, non-invasive Localized: Pathologic Examination: Polyp, NOS Submucosa, subserosal tissue/fat Operative Report, Discharge Summary, Consult Report: Confined to Colon, NOS Localized, NOS

Colo-Rectal Assigning Summary Stage Regional Direct Extension and Nodal Involvement: Pathology Report/Findings Endoscopy Operative Report Direct Extension Lymph Nodes Distant General and Site Specific Scans, X-rays Physical Exam Pathology Report

Prostate: Diagnostic Studies: Physical Exam: Palpable mass, size of nodule, nodularity, palpable lymph nodes, evidence of frozen pelvis, digital rectal exam Key words: Density, abnormal echo, abnormal density, mass effect Imaging: Prostatic Ultrasound, IVP, Chest Xray, Imaging Abdomen/Pelvis, Bone Scan, Liver-Spleen Scan, Lymphangiogram Endoscopies: Cystoscopy, Proctosigmoidoscopy, Laparoscopy

Prostate Assigning Summary Stage Surgical Pathology: Cell Type Tumor Grade Gleason s Grade or Score Tumor Size Capsule Invasion Invasion of Apex Lymph Nodes Extension to Adjacent Tissues Biopsy Results Structures Removed

In situ: Prostate Assigning Summary Stage Surgical Pathology Report, Non-invasive Operative Report/Discharge Summary: Stage 0 Localized: Surgical Pathology Report Invasion into prostatic capsule (but not beyond) Intracapsular involvement only Operative Findings/Discharge Summary Stage A or Stage B Localized, NOS

Prostate Assigning Summary Stage Regional Direct Extension: Physical Exam/Imaging: Fixation, NOS Pathology Report Extension through capsule Seminal Vesicles Operative Report - Cystoscopy Extension to Bladder neck, periprostatic tissue Regional Lymph Nodes: Pathology Report, Scans, Physical Exam

Prostate Assigning Summary Stage Distant Sites/Lymph Nodes: Pathology Report/Scans: Inguinal Lymph Nodes Para-aortic Nodes Frozen Pelvis Extension to/fixed to Pelvic Wall or Pelvic Bone Extension to: Penis, Sigmoid Colon Discharge Summary/Consult Reports: Stage D2 Stage D - NOS

Diagnostic Studies: Corpus Uteri History & Physical Pelvic Examination (including under anesthesia) Xrays and Scans Chest X-ray, Bone Survey, Liver/Spleen Scan, Lymphangiogram, Hysterosalpingogram Procedures: Culdoscopy, Cystoscopy, Hysteroscopy, Laparoscopy, Pelvic Ultrasound

Operative Report: Corpus Uteri Depth of uterus ("sounding" of uterus), Appearance and size of uterus, Extent of involvement of other abdominal organs (ovaries, adnexae, pelvic wall, pelvic tissues), Seeding, implants, encasement, nodularity of viscera, Frozen pelvis, any tumor on or in the liver that is not biopsied, which organs were removed (fallopian tubes, ovaries, lymph nodes), Location of tumor not resected, results of examination under anesthesia

Uterus Assigning Summary Stage Surgical Pathology: Histology Cell type Primary Site Tumor Size Depth of invasion Multifocal Tumors Direct Extension of Tumor FIGO Stage II-III Lymph Nodes Distant Spread: Surgical Observations Results of bone marrow aspiration/biopsy

In Situ: Uterus Assigning Summary Stage Pathology Report Consultation/Pre-admission work-up Localized: Pathologic Details re: Confined to Endometrium Invasion of Myometrium Operative Report/Consult/Discharge Summary: FIGO Stage IA, Stage IB, Stage IC or Stage I NOS

Uterus Assigning Summary Stage Regional Direct Extension: Operative report/consult Report/Discharge Summary: FIGO Stage II NOS, FIGO Stage IIA, FIGO Stage IIB Extension or Metastasis FIGO Stage IIIB Pathology/Cytology: Cancer Cells in Ascites Cancer Cells in Peritoneal Washings Regional Lymph Nodes: Xrays and Scans/Operative Report Aortic, NOS; Parametrial, Pelvic, NOS FIGO Stage IIIC

Uterus Assigning Summary Stage Distant Sites/Nodes: Physical Exam/Scans: Inguinal nodes, Other distant nodes Surgical Pathology Report/Operative Findings: Abdominal Serosa (peritoneum) Cul de sac (recto-uterine pouch) Sigmoid Colon Small Intestine Consult Report/Discharge Summary: FIGO Stage IV Carcinomatosis

Information Resources: SEER Summary Staging Manual 2000 Site Specific Guidelines for Summary Stage SEER Training Modules: http://training.seer.cancer.gov Site Specific Abstracting, Coding & Staging Key Information SEER Coding Manuals Historic 1977 http://www.seer.cancer.gov/archive/manuals/historic/abstracting- EOD.pdf Abstracting Instructions and Diagnostic Procedures

Summary: Summary Stage Background Features Timing Rule General Information Resources Site-specific Resources Are there any questions? cancerstaging@cdc.gov

Photo Title Myriad Pro, Bold, Shadow, 20pt Caption for photo, references, citations, or credits Myriad Pro, 14pt

Mary Lewis, CTR NPCR Public Health Advisor bkf5@cdc.gov For more information please contact Centers for Disease Control and Prevention 1600 Clifton Road NE, Atlanta, GA 30333 Telephone, 1-800-CDC-INFO (232-4636)/TTY: 1-888-232-6348 E-mail: cdcinfo@cdc.gov Web: www.cdc.gov The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion